« Back
Home /
PDE7-IN-3

PDE7-IN-3

Item no.	HY-100326-25mg
Manufacturer	MedChem Express
CASRN	908570-13-8
Amount	25 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 25 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.94
Formula	C18H21ClN2O4
Citations	[1]Cox Peter, et al. Use of combinations of PDE7 inhibitors and alpha-2-delta ligands for the treatment of neuropathic pain. World Intellectual Property Organization, WO2006092692 A1. 2006-09-08.
Smiles	O=C1NC2(CCCCC2)C(C(N1)=C3Cl)=C(C=C3)O[C@@H](C4)C[C@H]4C(O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Shipping condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Phosphodiesterase (PDE)
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	364.82
Product Description	Pde7-in-3 (example 2) is an inhibitor of the phosphodiesterase PDE7 with potential analgesic activity. PDE7-IN-3 can be used to study inflammatory, neuropathic, visceral and nociceptive pain[1].
Manufacturer - Research Area	Inflammation/Immunology; Neurological Disease
Solubility	DMSO : 100 mg/mL (ultrasonic; warming; heat to 80°C)
Manufacturer - Pathway	Metabolic Enzyme/Protease
Isoform	PDE7
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-100326-25mg-safety-datasheet.pdf